Northwestern Mutual Wealth Management
OTLK icon

Northwestern Mutual Wealth Management’s Outlook Therapeutics OTLK Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio OTLK Stock Details OTLK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.38K Sell
2,125
-171
-7% -$106 ﹤0.01% 3519
2026
Q1 		$472 Buy
2,296
+171
+8% +$74 ﹤0.01% 3860
2025
Q4 		$3.36K Hold
2,125
– – ﹤0.01% 3345
2025
Q3 		$2.25K Hold
2,125
– – ﹤0.01% 3359
2025
Q2 		$3.4K Hold
2,125
– – ﹤0.01% 3120
2025
Q1 		$2.59K Hold
2,125
– – ﹤0.01% 3089
2024
Q4 		$4.02K Hold
2,125
– – ﹤0.01% 3007
2024
Q3 		$11.3K Hold
2,125
– – ﹤0.01% 2644
2024
Q2 		$15.7K Hold
2,125
– – ﹤0.01% 2486
2024
Q1 		$25.4K Buy
+2,125
New +$17.2K ﹤0.01% 2329

Other funds holding OTLK

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
GWM
Gilpin Wealth Management Denver, Colorado $145M AUM

Northwestern Mutual Wealth Management's OTLK Position: Q2 2026 in Review

Northwestern Mutual Wealth Management reduced its Outlook Therapeutics (OTLK) stake by 7.4% in Q2 2026, selling an estimated $106 and leaving 2,125 shares worth $3.38K. The position accounts for ﹤0.01% of the portfolio, ranked #3519.

Northwestern Mutual Wealth Management first reported a position in OTLK in Q1 2024 and has held it in 10 quarters since. The position peaked at $25.4K in Q1 2024. 69 funds tracked by Wall St. Rank hold OTLK as of Q2 2026.

  • Northwestern Mutual Wealth Management held 2,125 shares of Outlook Therapeutics worth $3.38K as of Q2 2026.
  • Northwestern Mutual Wealth Management sold 171 Outlook Therapeutics shares in Q2 2026, an estimated $106.
  • Outlook Therapeutics made up ﹤0.01% of Northwestern Mutual Wealth Management's portfolio in Q2 2026, its #3519 holding.
  • Northwestern Mutual Wealth Management first reported a position in Outlook Therapeutics in Q1 2024 and has held it in 10 quarters since.
  • Northwestern Mutual Wealth Management's Outlook Therapeutics position peaked at $25.4K in Q1 2024.
  • 69 funds tracked by Wall St. Rank held Outlook Therapeutics as of Q2 2026.

Based on Northwestern Mutual Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.